Daniel Vejsig Stephansen
As Vice President of Digital Transformation of Novo Nordisk, Daniel oversees the implementation of a Digital Transformation strategy, specifically within drug development. This work includes harnessing AI, automation and data, more efficiently and effectively, as well as re-organization and centralization of processes.
Prior to his role at Novo Nordisk, Daniel worked on managing digital programs in AP at Moeller Maersk, before spending 7 years at LEO Pharma, where he held various leadership positions, ending as Head of Digital Strategy, Partnering and Analytics.
Daniels education has included studies in Computer Science at Aalborg University and Business Administration at Queensland University of Technology as well as Digital Transformation in Healthcare at Harvard Medical School.